Cite
HARVARD Citation
Ducoulombier, A. et al. (n.d.). 2294 Growth modulation index (GMI) to assess salvage chemotherapy benefit after FOLFIRINOX progression in metastatic pancreatic adenocarcinoma. European journal of cancer. pp. S430-. [Online].